IL17A and hypertensive disorder: Due to its pleiotropic character, IL-17A is involved in the development of atherosclerosis, hypertension, fibrosis, diabetic nephropathy, ischemia-reperfusion injury, glomerulonephritis, nephrotic syndrome, minimal change disease, and acute renal allograft rejection.